Literature DB >> 11292702

Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.

K Li1, J J Yu, C Y Hung, P F Lehmann, G T Cole.   

Abstract

Coccidioides immitis antigens which stimulate a T helper cell 1 (Th1) pathway of host immune response are considered to be essential components of a vaccine against coccidioidomycosis. Recombinant urease (rURE) and recombinant heat shock protein 60 (rHSP60) of C. immitis were expressed in Escherichia coli and tested as vaccine candidates in BALB/c mice. A synthetic oligodeoxynucleotide which contained unmethylated CpG dinucleotides and was previously shown to enhance a murine Th1 response was used as an immunoadjuvant. T cells isolated from the spleens and lymph nodes of the rURE- and rHSP60-immune mice showed in vitro proliferative responses to the respective recombinant protein, but only those T lymphocytes from rURE-immunized mice revealed markedly elevated levels of expression of selected Th1-type cytokine genes. BALB/c mice immunized subcutaneously with rURE and subsequently challenged by the intraperitoneal (i.p.) route with a lethal inoculum of C. immitis arthroconidia demonstrated a significant reduction in the level of C. immitis infection compared to control animals. rHSP60 was much less effective as a protective antigen. Evaluation of cytokine gene expression in lung tissue and levels of recombinant urease-specific immunoglobulins (immunoglobulin G1 [IgG1] versus IgG2a) in murine sera at 12 days after challenge provided additional evidence that immunization with rURE stimulated a Th1 response to the pathogen. Urease was further evaluated by expression of the URE gene in a mammalian plasmid vector (pSecTag2A.URE) which was used to immunize mice by the intradermal route. In this case, 82% of the vector construct-immunized animals survived more than 40 days after i.p. infection, compared to only 10% of the mice immunized with the vector alone. In addition, 87% of the pSecTag2A.URE-immunized survivors had sterile lungs and spleens. These data support the need for further evaluation of the C. immitis urease as a candidate vaccine against coccidioidomycosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292702      PMCID: PMC98238          DOI: 10.1128/IAI.69.5.2878-2887.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Purification of the spherule-endospore phase of Coccidioides immitis.

Authors:  H B LEVINE
Journal:  Sabouraudia       Date:  1961-06

2.  A major cell surface antigen of Coccidioides immitis which elicits both humoral and cellular immune responses.

Authors:  C Y Hung; N M Ampel; L Christian; K R Seshan; G T Cole
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  An immunoreactive, water-soluble conidial wall fraction of Coccidioides immitis.

Authors:  G T Cole; T N Kirkland; S H Sun
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

4.  Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules.

Authors:  C R Zimmermann; S M Johnson; G W Martens; A G White; B L Zimmer; D Pappagianis
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

5.  Mechanisms of resistance to infection with Coccidioides immitis in mice.

Authors:  L V Beaman; D Pappagianis; E Benjamini
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

6.  Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody.

Authors:  A Svetić; F D Finkelman; Y C Jian; C W Dieffenbach; D E Scott; K F McCarthy; A D Steinberg; W C Gause
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

7.  Sequence, expression and functional analysis of the Coccidioides immitis ODC (ornithine decarboxylase) gene.

Authors:  L Guevara-Olvera; C Y Hung; J J Yu; G T Cole
Journal:  Gene       Date:  2000-01-25       Impact factor: 3.688

Review 8.  Coccidioidomycosis: a regional disease of national importance. Rethinking approaches for control.

Authors:  J N Galgiani
Journal:  Ann Intern Med       Date:  1999-02-16       Impact factor: 25.391

9.  Inbred mouse strains differ in resistance to lethal Coccidioides immitis infection.

Authors:  T N Kirkland; J Fierer
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

10.  DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge.

Authors:  L Vanderzanden; M Bray; D Fuller; T Roberts; D Custer; K Spik; P Jahrling; J Huggins; A Schmaljohn; C Schmaljohn
Journal:  Virology       Date:  1998-06-20       Impact factor: 3.616

View more
  19 in total

1.  Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses.

Authors:  Ashok K Chaturvedi; Susan T Weintraub; Jose L Lopez-Ribot; Floyd L Wormley
Journal:  Proteomics       Date:  2013-12       Impact factor: 3.984

Review 2.  Early Events in Coccidioidomycosis.

Authors:  Fariba M Donovan; Lisa Shubitz; Daniel Powell; Marc Orbach; Jeffrey Frelinger; John N Galgiani
Journal:  Clin Microbiol Rev       Date:  2019-10-16       Impact factor: 26.132

3.  Urease produced by Coccidioides posadasii contributes to the virulence of this respiratory pathogen.

Authors:  Fariba Mirbod-Donovan; Ruth Schaller; Chiung-Yu Hung; Jianmin Xue; Utz Reichard; Garry T Cole
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.

Authors:  Eric J Tarcha; Venkatesha Basrur; Chiung-Yu Hung; Malcolm J Gardner; Garry T Cole
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  A metalloproteinase of Coccidioides posadasii contributes to evasion of host detection.

Authors:  Chiung-Yu Hung; Kalpathi R Seshan; Jieh-Juen Yu; Ruth Schaller; Jianmin Xue; Venkatesha Basrur; Malcolm J Gardner; Garry T Cole
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 6.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.

Authors:  Roger A Herr; Chiung-Yu Hung; Garry T Cole
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

8.  Progress Toward a Human Vaccine Against Coccidioidomycosis.

Authors:  Garry T Cole; Brady J Hurtgen; Chiung-Yu Hung
Journal:  Curr Fungal Infect Rep       Date:  2012-12-01

9.  Vaccine-induced cellular immune responses differ from innate responses in susceptible and resistant strains of mice infected with Coccidioides posadasii.

Authors:  Lisa F Shubitz; Sharon M Dial; Robert Perrill; Rachael Casement; John N Galgiani
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

10.  Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate.

Authors:  Kris I Orsborn; Lisa F Shubitz; Tao Peng; Ellen M Kellner; Marc J Orbach; Paul A Haynes; John N Galgiani
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.